The recent article by Schmid et al 1 reports the results of a window-of-opportunity study of pictilisib in patients with estrogen receptor–positive breast cancer. In this study, the addition of ...

Supported in part by the National Institutes of Health/National Cancer Institute through Cancer Center Support Grant P30CA016672 to The University of Texas MD Anderson Cancer Center. P.M. and E.B.L.